The 32 references in paper A. Shevchenko V., O. Golovanova V., V. Konenkov I., M. Voevoda I., V. Maximov N., O. Tolkacheva M., А. Шевченко В., О. Голованова В., В. Коненков И., М. Воевода И., В. Максимов Н., О. Толкачева М. (2014) “АНАЛИЗ ВЗАИМОСВЯЗИ ПОЛИМОРФИЗМА ГЕНА IL6 (-174 G/C) И КЛАССИЧЕСКИХ ФАКТОРОВ РИСКА У ПАЦИЕНТОВ С ОСТРЫМ ИНФАРКТОМ МИОКАРДА В АНАМНЕЗЕ // ANALYSIS OF CORRELATION BETWEEN IL 6 GENE POLYMORPHISM (-174 G /C) AND CLASSIC RISK FACTORS IN PATIENTS WITH PREVIOUS MYOCARDIAL INFARCTIONS” / spz:neicon:mimmun:y:2009:i:6:p:557-566

1
Богова О.Т., Чукаева И.И. Инфаркт миокарда. Воспаление и прогноз // Российский кардиологический журнал.– 2003. – No 4. – С. 18 - 23.
(check this in PDF content)
2
Доценко Э.А., Юпатов Г.И., Чиркин А.А. Холестерин и липопротеины низкой плотности как эндогенные иммуномодуляторы // Иммунопатология, аллергология, инфектология. – 2001. – No 3. – С. 6-15.
(check this in PDF content)
3
Лутай М.И. Атеросклероз: современный взгляд на патогенез. – http: //www.rql.kiev.ua/cardio_j/2004/1/lutay.htm.
(check this in PDF content)
4
Школьник В.В. Динамика уровня интерлейкина-6 у больных с острым инфарктом миокарда при лечении ингибиторами ангиотензинпревращающего фермента // Украинський терапевтичний журнал. – 2004. – No 1. – С. 74 - 76.
(check this in PDF content)
5
Basso F., Lowe G.D.O., Rumley A., McMahon A.D., Humphries S.E. Interleukin-6- 174 G > C Polymorphism and Risk of Coronary Heart Disease in West of Scotland Coronary Prevention Study (WOSCOPS), on behalf of the WOSCOPS Group // Arterioscler Thromb. Vasc. Biol. – 2002. – Vol. 22. – P. 599-604.
(check this in PDF content)
6
Bennermo M., Held C., Stemme S., Ericsson C.-G., Silveira A., Green F., Tornvall P. Genetic Predisposition of the Interleukin-6 Response to Inflammation: Implications for a Variety of Major Diseases? // Clinical Chemistry. – 2004. – Vol. 50, – N 11. – P. 2136-2140.
(check this in PDF content)
7
Bland J. M., Altman D.G., Education and debate. The odds ratio // BMJ. – 2000. – Vol. 320. – P. 1468.
(check this in PDF content)
8
Brull D.J., Montgomery H.E., Sanders J., Dhamrait S., Luong L., Rumley A., Lowe G.D.O., Humphries S.E. Atherosclerosis and Lipoproteins Interleukin-6 Gene -174 G > C and -572 G > C Promoter Polymorphisms Are Strong Predictors of Plasma Interleukin-6 Levels After Coronary Artery Bypass Surgery // Arterioscler Thromb Vasc Biol.- 2001. – Vol. 21. – P. 1458-1463.
(check this in PDF content)
9
Crea F., Biasucci L.M., Buffon A., Liuzzo G., Monaco C., Caligiuri G., Kol A., Sperti G., Cianflone D., Maseri A. Role of inflammation in the pathogenesis of unstable coronary artery disease // Am. J. Cardiol. – 1997. – Vol. 80. – P. 10-16.
(check this in PDF content)
10
Fernandez-Real J.-M., Broch M., Vendrell J., Bal Richart C., Ricart W. Interleukin-6 Gene Polymorphism and Lipid Abnormalities in Healthy Subjects // J. Clin. Endocrinol. Metab. – 2000. – Vol. 85. – P. 1334-1339.
(check this in PDF content)
11
Fernandez-Real J.-M., Vendrell J.N, Richart C., Gutierrez C., Ricart W. Platelet count and Interleukin 6 Gene polymorphism in healthy subjects // BMC Medical Genetics. – 2001. – Vol. 2, N 6. – P. 1471 - 2350.
(check this in PDF content)
12
Freeman D.J., Griffin B.A., Murray E. Smoking and plasma lipoproteins in man: effects on low density lipoprotein cholesterol levels and high density lipoprotein subfraction distribution // Eur. J. Clin. Invest. – 1993. – Vol. 23. – P. 630-640.
(check this in PDF content)
13
Gabriel A,S., Ahnve S., Wretlind B., Martinsson A. IL-6 and IL-1 receptor antagonist in stable angina pectoris and relation of IL-6 to clinical findings in acute myocardial infarction //J. Intern. Med. – 2000. – Vol. 248. – P. 61-66.
(check this in PDF content)
14
Cardellini M., Perego L., D’Adamo M., Marini M.A., Procopio C., Hribal M.L., Andreozzi F., Frontoni S., Giacomelli M., Paganelli M., Pontiroli A.E., Lauro R., Folli F., Sesti G. C -174G Polymorphism in the Promoter of the Interleukin-6 Gene Is Associated With Insulin Resistance // Diabetes Care. – 2005. – Vol. 28. – P. 2007-2012.
(check this in PDF content)
15
Georges J.-L., Loukaci V., Poirier O., Evans A.L.G., Ruidavets D.A.J.-B., Cambien F., Tiret L. Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: the ECTIM study // J. Mol. Med. – 2001. – Vol. 79. – P. 300- 305.
(check this in PDF content)
16
Goyenechea E., Parra D., Martínez J.A. Role of IL-6 and its-174 G > C polymorphism in weight management and in the metabolic comorbidities associated with obesity // An Sist. Sanit. Navar. – 2005. – Vol. 28, N 3. – P. 357-366.
(check this in PDF content)
17
Goyenechea E., Parra D., Martínez J.A. Impact of interleukin 6-174 G > C polymorphism on obesity-related metabolic disorders in people with excess in body weight // Metabolism. – 2007. – Vol. 56, N 12. – P. 1643-1648.
(check this in PDF content)
18
Henningsson S., Håkansson A., Westberg L., Baghaei F., Rosmond R., Holm G., Ekman A., Nissbrandt H., Eriksson E. Interleukin-6 Gene Polymorphism -174 G/C Influences Plasma Lipid Levels in Women // OBESITY. – 2006. – Vol. 14, N 11. – P. 1868-1873.
(check this in PDF content)
19
Humphries1 S.E., Luong1 L.A., Ogg1 M.S., Hawe1 E., Miller G.J. The interleukin-6 - 174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men // European Heart Journal. – 2001. – Vol. 22. – P. 2243-2252.
(check this in PDF content)
20
Jones K.G., Brull D.J., Brown L.C., Greenhalgh R.M., Humphries S.E., Powell J.T. Interleukin-6 (IL-6) and the Prognosis of Abdominal Aortic Aneurysms // Circulation. – 2001. – Vol. 103. – P. 2260-2265.
(check this in PDF content)
21
Lieb W., Pavlik R., Erdmann J., Mayer B., Holmer S.R., Fischer M., Baessler A., Hengstenberg C., Loewel H., Doering A., Riegger G.A., Schunkert H. No association of interleukin-6 gene polymorphism (-174 G/C) with myocardial infarction or traditional cardiovascular risk factors // Int. J. Cardiol. – 2004. – Vol. 97, N 2. – P. 205-212.
(check this in PDF content)
22
Lowe G.D.O., Rumley A. Coagulation, fibrinolysis and cardiovascular disease // Fibrinolysis & Proteolysis. – 1999. – Vol. 13. – P. 91-98.
(check this in PDF content)
23
Lusis A.J., Fogelman A.M., Fonarow G.C. Genetic basis of atherosclerosis. II. Clinical implications // Circulation. – 2004. – Vol. 110. – P. 2066-2071.
(check this in PDF content)
24
Ridker P.M., Rifai N., Stampfer M.J., Hennekens C.H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men // Circulation. – 2000. – Vol. 101. – P. 1767-1772.
(check this in PDF content)
25
Seed M., Humphries S.E., Ayres K.L., Miller G.J. Lipoprotein (a) as a predictor for myocardial infarction in the Second Northwick Park Heart Study — a prospective study in middle-aged men //Am. J. Med. – 2001. – Vol. 110. – P. 22-27.
(check this in PDF content)
26
Signorelli S.S., Mazzarino M.C., Di Pino L. High circulating levels of cytokines (IL-6 and TNFalpha), adhesion molecules (VCAM-1 and ICAM-1) and selectins in patients with peripheral arterial disease at rest and after a treadmill test // Vasc. Med. – 2003. – Vol. 8. – P. 15-19.
(check this in PDF content)
27
Takano M., Itoh N., Yayama K., Yamano M., Ohtani R.,Okamoto H. Interleukin-6 as a mediator responsible for inflammation-induced increase in plasma angiotensinogen // Biochem. Pharmacol. – 2000. – Vol. 45. – P. 201-206.
(check this in PDF content)
28
Tretjakovs P., Latkovskis G., Licis N., Juhnevica D., Jurka A., Bormane I., Aivars J.I., Stifts A., Pirags V. Lnterleukin-6 gene promoter -174 G/C polymorphism and insulin resistance: a pilot study // Clinical chemistry and laboratory medicine. – 2007. – Vol. 45, N 9. – P. 1145-1148.
(check this in PDF content)
29
Verheye S., De Meyer R.Y., Langenhove G.V. In vivo temperature heterogeneity of atherosclerotic plaques is determined by plaque composition // Circulation. – 2002. – Vol. 105, N 13. – P. 1596 - 1601.
(check this in PDF content)
30
Woodward M., Rumley A., TunstallPedoe H., Lowe G.D.O. Associations of blood rheology and interleukin-6 with cardiovascularrisk factors and prevalent cardiovascular disease // Br. J. Haematology. – 1999. – Vol. 104. – P. 246-257.
(check this in PDF content)
31
Xenophontos S., Hadjivassiliou M., Karagrigoriou A., Demetriou N., Miltiadous G., Marcou I., Elisaf M., Mikhailidis D.P., Cario lou M.A. Low HDL Cholesterol, Polymorphism are Associated with Myocardial Infarction in Greek Cypriot Males. A Pilot Study // The Open Cardiovascular Medicine Journal. – 2008. – Vol. 2. – P. 52-59.
(check this in PDF content)
32
Yudkin J.S., Stehouwer C.D.A., Emeis J.J. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction – a potential role for cytokines originating from adipose tissue? // Arterioscler.
(check this in PDF content)